A new theranostic pH-responsive niosome formulation for doxorubicin delivery and bio-imaging against breast cancer
S Saharkhiz, A Zarepour, A Zarrabi - International Journal of Pharmaceutics, 2023 - Elsevier
As one of the newest generations of nanoplatforms, smart nanotheranostics have attracted
signifivant attentions for medical applications, especially in oncology and cancer treatment …
signifivant attentions for medical applications, especially in oncology and cancer treatment …
Folic acid-functionalized niosomal nanoparticles for selective dual-drug delivery into breast cancer cells: An in-vitro investigation
In this study, a folic acid-functionalized niosome was formulated and loaded with letrozole
and curcumin as a promising drug carrier system for chemotherapy of the breast cancer …
and curcumin as a promising drug carrier system for chemotherapy of the breast cancer …
[HTML][HTML] Co-delivery of letrozole and cyclophosphamide via folic acid-decorated nanoniosomes for breast cancer therapy: synergic effect, augmentation of cytotoxicity …
H Sahrayi, E Hosseini, S Karimifard, N Khayam… - Pharmaceuticals, 2021 - mdpi.com
Breast cancer is one of the most prevalent causes of cancer mortality in women. In order to
increase patient prognosis and survival rates, new technologies are urgently required to …
increase patient prognosis and survival rates, new technologies are urgently required to …
[HTML][HTML] A comparison study between doxorubicin and curcumin co-administration and co-loading in a smart niosomal formulation for MCF-7 breast cancer therapy
S Saharkhiz, A Zarepour, N Nasri, M Cordani… - European Journal of …, 2023 - Elsevier
Chemotherapy agents often exhibit limited effectiveness due to their fast elimination from the
body and non-targeted delivery. Emerging nanomaterials as drug delivery carriers open …
body and non-targeted delivery. Emerging nanomaterials as drug delivery carriers open …
pH-responsive chitosan-adorned niosome nanocarriers for co-delivery of drugs for breast cancer therapy
S Karimifard, N Rezaei, E Jamshidifar… - ACS Applied Nano …, 2022 - ACS Publications
Breast cancer incidence has increased in recent decades. In the present study, an optimum
formulation of chitosan (CS)-adorned niosome-based nanocarriers for co-delivery of …
formulation of chitosan (CS)-adorned niosome-based nanocarriers for co-delivery of …
[HTML][HTML] Niosomal formulation for co-administration of hydrophobic anticancer drugs into MCF-7 cancer cells
I Akbarzadeh, M Fatemizadeh, F Heidari… - Archives of Advances in …, 2020 - ojs3.sbmu.ac.ir
Introduction: Designing and developing drug delivery systems has received tremendous
attention during the last decade. The treatment of cancer cells is a complicated process due …
attention during the last decade. The treatment of cancer cells is a complicated process due …
Smart stimuli-responsive biofunctionalized niosomal nanocarriers for programmed release of bioactive compounds into cancer cells in vitro and in vivo
Cancer treatment is challenging due to late-stage diagnosis, drug resistance and systemic
toxicity of chemotherapeutic agents. The formulation of the drug into nanoparticles (NPs) can …
toxicity of chemotherapeutic agents. The formulation of the drug into nanoparticles (NPs) can …
Preparation, optimization and in-vitro evaluation of curcumin-loaded niosome@ calcium alginate nanocarrier as a new approach for breast cancer treatment
I Akbarzadeh, M Shayan, M Bourbour, M Moghtaderi… - Biology, 2021 - mdpi.com
Simple Summary We provided an effective approach for the treatment of breast cancer as a
malignant disease. Regards to this, we used drug delivery system. This approach does not …
malignant disease. Regards to this, we used drug delivery system. This approach does not …
Folic Acid-Decorated pH-Responsive Nanoniosomes With Enhanced Endocytosis for Breast Cancer Therapy: In Vitro Studies
T Rezaei, M Rezaei, S Karimifard… - Frontiers in …, 2022 - frontiersin.org
Breast cancer is the most common invasive cancer in women and the second leading cause
of cancer death in women after lung cancer. The purpose of this study is a targeted delivery …
of cancer death in women after lung cancer. The purpose of this study is a targeted delivery …
Carboplatin niosomal nanoplatform for potentiated chemotherapy
This study aimed to characterize a stable nano-niosome formulation, which could reduce the
adverse effects of carboplatin (CB) and improve its therapeutic efficacy in the treatment of …
adverse effects of carboplatin (CB) and improve its therapeutic efficacy in the treatment of …